CI Systems 2025: Record Revenue, but the WETALYZER Proof Year Is Only Beginning

Introduction to the Company

CI Systems is neither a chip company nor a large defense prime. It is a niche supplier of electro-optic test and measurement systems, operating across three very different arenas: defense-scientific equipment, microelectronics equipment, and a small SENSING activity. In 2025 it ended the year with record revenue of $48.5 million, net income of $2.0 million, and a $34.3 million backlog as of March 18, 2026. What is working now is clear: the defense segment provides scale, microelectronics has returned to growth, and the balance sheet is clean enough that the core question is execution rather than refinancing.

But this is still not a clean thesis. The 2025 growth story leaned mainly on the defense segment and on a first batch of WETALYZER systems that were delivered and recognized as revenue, while the new business line has not yet proven repeatability. At the same time, one customer, Elbit Group, reached 21.9% of consolidated sales, trade receivables rose by $3.4 million, and the cash left after real uses was close to zero. There is also a practical market constraint. In the April 3, 2026 trading snapshot, market value stood at roughly NIS 488 million, but daily turnover was only about NIS 42.6 thousand. This is a stock whose business story can improve faster than the market's ability to trade it smoothly.

A superficial read can easily miss that point. On one level, 2025 looks like a breakout year: record revenue, a strong fourth quarter, bigger backlog, a Taiwan subsidiary, and a new branch in South Korea. On another level, the economics are still not back to peak form. Operating profit recovered to $2.65 million after only $279 thousand in 2024, but it remained below the $4.95 million recorded in 2023. Scale is back. Full economic quality is not.

• 2025 was driven more by defense than by a full tech breakout. The defense-scientific segment supplied 77% of revenue, with sales rising to $37.4 million and backlog reaching $29.5 million at year-end.
• The new story is WETALYZER, but it is still in proof mode. The system moved from development into first commercial deliveries worth more than $4 million to a leading Asian chipmaker, yet microelectronics backlog stayed at $2.75 million even in March 2026.
• Cash flow improved, but very little cash remained after real uses. Cash from operations was $1.66 million, but after reported capital expenditure, intangible investment and lease cash outflow, all-in cash flexibility was still negative by about $0.17 million.
• The stock is not under short pressure, but liquidity is weak. Short float stood at 0.00% at the end of March 2026, so the immediate market problem is not bearish positioning but thin trading.

What matters most is the structure of the story. The market can easily read CI Systems either as a defense equipment supplier benefiting from larger security budgets, or as a semiconductor equipment name with technology optionality. In practice it sits between those two worlds. As of 2025, the money still comes mainly from the defense side. What could change the multiple in the future is microelectronics, and within that, whether WETALYZER becomes a repeatable commercialization path rather than a successful first delivery.

Events and Triggers

The core takeaway here is that 2025 changed the company's pace, but not yet the quality test of the new level. Almost every positive trigger came with an open question attached.

Trigger One: WETALYZER Moved from Story to Delivery and Revenue Recognition

This is the center of the new thesis. Since 2023 the company has been developing WETALYZER, an automatic liquid monitoring system aimed directly at chip manufacturers rather than only at tool OEMs. By the signing date of the report, the system was described as being in advanced development stages. Early in 2025 the company received orders worth more than $4 million from a leading Asian chip producer. Those systems were delivered during the year, some passed ACCEPTANCE, were placed on production lines, and revenue was recognized.

That matters for two reasons. First, it proves the company can sell a larger, more expensive, more direct product to the end customer. Second, it changes the risk profile. Once the company sells a full system directly to a FAB, it is closer to the end customer, but it also takes on more support, more execution burden and more pressure to prove repeatability.

Trigger Two: Taiwan and South Korea Bring the Company Closer to the Market, but Raise the Execution Bar

The Taiwan subsidiary was established at the beginning of 2025. After the balance sheet date, at the beginning of 2026, the company also set up a local branch in South Korea, still at an early stage. Both moves are intended to support marketing, sales, production and support for the microelectronics division.

Strategically, this makes sense. A company selling into semiconductors cannot remain only an Israel-based organization and expect the whole market to be served by agents. But this is also a cost and execution layer. That is why 2026 looks like a proof year for the move rather than a harvest year.

Trigger Three: The Defense Segment Gives Stability, but Also Deepens Concentration

The defense-scientific segment finished the year with record sales of $37.4 million and backlog of $31.5 million already by March 18, 2026. This is the current anchor of the business. The company explicitly links the increase in orders and sales to higher defense spending in Israel and in other countries.

But the second layer is less comfortable. Elbit Group alone already represented 21.9% of consolidated sales in 2025, up from 13.7% in 2024 and 10.3% in 2023. Part of the growth story that can easily be read as broad defense demand is, in practice, sitting on higher customer concentration.

Trigger Four: Growth Is Getting Closer to the Capacity of the Existing Footprint

The company estimates that its current manufacturing setup can support annual revenue of roughly $50 million to $60 million, while 2025 sales already reached $48.5 million. Based on the product mix of the year, it estimates actual utilization at about 85%, and it is examining options for additional rented space.

That matters because the next bottleneck is not theoretical demand alone. If momentum continues, the company will need more space and more people. That is positive from a business-development standpoint, but the transition phase usually weighs on cash flow and efficiency.

Trigger Five: The US Has Become a Harder Market, Not Just a Bigger One

From April 2025, the US imposed reciprocal tariffs on imports from many countries, including Israel, and the company states explicitly that the systems it sells into the US are subject to a 15% tariff. According to the company, these tariffs affect business results and make competition in the US harder. It also says that since 2023 it has felt stronger regulation and local-production preference in Europe, India and China.

So anyone reading CI Systems only through the lens of stronger defense demand or semiconductor upside misses the point that end-markets themselves have become harder for an Israeli exporter.

Efficiency, Profitability and Competition

The main story of 2025 is not just growth but the gap between growth and profit quality. The company sold much more, returned to operating profit, and increased the weight of microelectronics, but margins did not open up the way a quick read might suggest.

Microelectronics Is More Profitable than Defense, but It Is Also the Segment Under Proof Pressure

In 2025, microelectronics sales jumped 63% to $10.6 million, and the segment generated gross profit of $4.34 million, or about 41% of sales. That is still better than the defense segment, where gross margin was 34%.

But this is exactly where the key nuance sits. Microelectronics gross margin actually fell from 47.3% in 2024 to 41.0% in 2025 despite the revenue surge. The company attributes that to higher raw material prices, a higher material-content ratio in sales, and the decline in the dollar toward year-end. In other words, the segment that could become the future profitability engine is already growing, but it is growing with more material, more cost and more execution sensitivity.

Higher Micro Mix Helped the Blend, but Not Enough to Open the Consolidated Margin

Microelectronics rose to 22% of consolidated sales in 2025 from 19% in 2024, and in the fourth quarter it was already about 36% of quarterly sales. Normally that should help the consolidated gross margin, because the segment is structurally more profitable than defense. In practice, total gross margin stayed almost flat at 35.6% versus 35.8% in 2024.

The company explains why. The weaker dollar versus the shekel and higher raw material costs ate into part of the mix benefit. The average USD/ILS rate during the year was 3.45 versus 3.7 in 2024, and by year-end the dollar had fallen to 3.19 versus 3.647 a year earlier. For a company with a meaningful shekel cost base, that means wages and other local expenses became more expensive in dollar terms.

What Looks Like Broad Growth Actually Rests on Two Concentration Points

In defense-scientific, Elbit Group alone already represented 21.9% of total consolidated sales. That is too large to call comfortable diversification. In microelectronics the picture is different but not calm. The largest customer represented 30% of segment sales in 2025, while additional customers were at 13%, 10%, 6% and 6%. Not all of them are material at the group level, but they are very material for understanding the quality of the segment's growth.

The report also states explicitly that in microelectronics the company grants unit-price discounts to customers for larger quantities. That is not a problem by itself, but it is a reminder that growth is not automatically proof of pricing power.

The Company Is Scaling, but It Is Also Spending More to Produce That Growth

Research and development expense rose to $3.69 million from $3.44 million, mainly because of WETALYZER. Selling and marketing expense rose to $8.15 million from $6.05 million, and the company explicitly says that wages, commissions and US tariffs were among the drivers. General and administrative expense rose to $2.78 million from $2.24 million.

This is why 2025 is a recovery year rather than a harvest year. The company is generating higher sales, but it is also spending on development, geographic build-out and support, so every extra dollar of growth still has to pass through a cost base that is rising with it.

What matters is that the company has already proven demand, but it has not yet proven that the new profit structure is stable. If 2026 shows that microelectronics can keep growing without further margin pressure, the market's read on the whole company can change. If the growth remains expensive, the larger weight of the segment will not automatically justify a different valuation.

Cash Flow, Debt and Capital Structure

This is where the distinction between two cash frameworks matters. If one looks at normalized cash generation, the business has returned to positive operating cash flow. But if one looks at all-in cash flexibility, meaning how much cash remains after the year's real uses, the picture is still not clean.

The All-In Cash Picture: Close to Flat, Not More

Cash flow from operations reached $1.66 million, versus negative $1.44 million in 2024. That is a real improvement, but it is not the full story. After $1.04 million of capital expenditure, $58 thousand of intangible investment, and $731 thousand of lease-related cash outflow, the all-in cash picture was still slightly negative, by about $172 thousand.

That is exactly why it is too early to call the company fully self-funding. The underlying business improved. The actual cash left after hard uses did not yet become comfortably positive.

The Cash Increase Did Not Come Only from Operations

Cash rose by $2.38 million to $11.56 million, but it would be wrong to attribute all of that increase to better operating cash generation. During 2025 the company sold $2.25 million of securities, and investing activity as a whole was positive by $1.26 million. So part of the stronger cash balance came from balance-sheet simplification, not only from deeper cash-generation power in the operating model.

What Really Ate the Cash Flow

Working capital was the biggest factor. Trade receivables rose by $3.38 million, mainly in defense-scientific. Inventory rose by another $316 thousand, and tax payments totaled $1.06 million. Those uses were partly offset by a $478 thousand increase in suppliers, a $1.37 million increase in payables and accrued expenses, and a $428 thousand increase in customer advances.

In simple terms, 2025 proved the company can grow, but it also proved that the current growth still consumes working capital.

The Balance Sheet Itself Is Still Strong

This part is actually comfortable. As of the report date the company had no loans from financial institutions, and no material contracts exposed to interest-rate increases. It has a small bank credit line at prime plus 2% that was unused, and bank guarantees of roughly $44 thousand. It has fixed liens securing that credit line, but no additional liens.

Even leases do not make the balance sheet pressured. They simply need to be framed correctly. Lease liabilities stood at $4.10 million at year-end 2025, against $11.56 million of cash and cash equivalents. The company can carry this comfortably, but lease cash is still a real use of cash and should not be ignored.

FX Exposure Remains Material Even with Partial Hedging

The company describes a policy of partial hedging of shekel-based expense exposure and certain short-term balance sheet items through derivatives. Even so, the sensitivity analysis shows that a 5% move in the shekel versus the dollar would have affected 2025 profit or loss by about $1.31 million to $1.45 million. For a company of this size, that is not a small number.

The investor implication is straightforward. CI Systems is not an immediate financing-stress story, but it is also not yet at the point where its growth can be called clearly self-funded without qualification. The business is generating more, but the improvement is not yet leaving a comfortable cash surplus after real uses.

Forward Look and Guidance

Finding one: The defense segment gives the company a stronger base for 2026, but it also deepens customer concentration.

Finding two: WETALYZER has already proven that a sale can be won, a system can be delivered, and revenue can be recognized, but it has not yet proven repeat demand.

Finding three: The 2025 growth restored operating profit, but it did not free up cash after hard uses.

Finding four: 2026 looks like a proof year. Not a reset year, not a survival year, and not yet a clean breakout year.

That is probably the most accurate definition of the coming year. On the positive side, the starting point is stronger: total backlog of $32.65 million at the end of 2025 rose to $34.29 million by March 18, 2026, and defense backlog alone rose from $27.7 million at the end of 2024 to $29.5 million at year-end 2025 and $31.5 million in March 2026. On the less comfortable side, microelectronics backlog fell from $3.0 million at the end of 2024 to $2.75 million at the end of 2025 and remained $2.75 million in March 2026.

That is the most important data point for reading 2026. The company has already sold the first generation of the new system, but it has not yet shown that those deliveries are feeding a larger backlog at a faster pace. So 2026 has to answer whether 2025 was the first year of penetration or mainly a very good first example.

What Has to Happen for the Thesis to Strengthen

First, WETALYZER has to become repeatable. The company itself plans around $4.5 million of 2026 R&D expense, mainly for WETALYZER. That is a reasonable investment if the product is on its way to becoming a broad platform. It is much less comfortable if the product remains largely a customized project for one major customer.

Second, working capital has to behave better. If receivables continue to rise faster than sales, and if microelectronics inventory remains heavy, another good revenue year will still not translate automatically into clean surplus cash.

Third, the company will need to expand capacity without opening up too much additional cost. Manufacturing capacity of $50 million to $60 million against 2025 revenue of $48.5 million means the next growth leg is already encountering real physical limits in space and staffing.

Fourth, the defense segment has to keep growing without becoming even more concentrated. Otherwise, what looks today like a strong demand moat could tomorrow be read as excessive dependence on one customer or one market.

What Could Surprise the Market Positively or Negatively

A genuine positive surprise would be a combination of two things: continued defense momentum alongside follow-on microelectronics orders, so the market starts to see the new segment as more than optionality.

A negative surprise would be if microelectronics backlog remains flat or weak despite the 2025 revenue jump, while receivables and inventory continue to weigh on cash flow. In that case, 2025 would look more like pulled-forward revenue than a new operating level.

Put differently, 2026 is a proof year for growth quality. If the company shows repeat microelectronics demand, better cash conversion and defense growth that does not become even more concentrated, the market can start reading CI Systems differently. If not, it will continue to be seen primarily as a good defense-scientific supplier with technology optionality that has not fully matured.

Risks

Customer Concentration Is Higher than the Market Would Prefer

Elbit Group already accounted for 21.9% of consolidated sales. That is not a theoretical risk but an actual concentration in the revenue base. Even if the relationship is longstanding, any change in order volume or timing would materially change the picture.

In microelectronics the issue is similar in a different form. The market is small, the number of potential customers is limited, and the company itself says that the larger players in the field can pressure both suppliers and customers and obtain favorable terms. So even where consolidated dependence looks smaller, bargaining power on the customer side is still strong.

FX, Tariffs and Supply Chain Pressure Can Still Eat the Margin

The company hedges part of the exposure, but it cannot eliminate it. Sensitivity of more than $1 million to a 5% shekel move is material for a company of this size. US tariffs already affected 2025 results, and the company also describes a broader trend of local-production preference in key markets.

In addition, both main segments are exposed to component availability and raw-material supply. In microelectronics the company explicitly talks about delivery-time volatility because of possible shortages in electronic components and other inputs. This is not only a cost question. It is also a revenue-timing question.

Inventory in Microelectronics Is Heavy, Which Raises the Cost of Getting the Thesis Wrong

Average inventory days in microelectronics were about 815 days in 2025, versus about 803 days in 2024. At the same time, total group inventory stood at $14.19 million, including $5.25 million of work in process. That does not automatically mean inventory is problematic, but it does mean the new segment is more capital-intensive and more exposed to demand timing or execution slippage.

The Legal Risk Is Still Open-Ended

After the balance sheet date, on February 3, 2026, the company received a motion for certification of a class action relating to the Packaging Law. The stated amount of the representative claim was above NIS 2.5 million, and the company said that at this early stage it could not assess the chances of the request or its effect, if any. This is not the central thesis risk, but it is an open one.

Thin Liquidity Can Leave a Gap Between a Better Thesis and Market Response

The market message is short. Short interest is negligible, but daily volume is very low. So even if 2026 improves operationally, market reaction may still be slow, sharp and discontinuous. That is not a business problem, but it is a real trading constraint.

---

Conclusions

CI Systems ended 2025 in a better place than it looked a year earlier. Revenue is at a record, profit is back, there is no bank debt, and the defense segment provides a real backlog cushion. But this is still not a clean multi-engine breakout story. The main bottleneck has simply moved: can the new microelectronics engine, especially WETALYZER, become repeatable, and can more of the operating improvement remain in cash after real cash uses?

In the short to medium term, the market is likely to react less to the headline revenue number and more to three tests: repeat demand in microelectronics, conversion of the defense backlog, and whether working capital stops consuming most of the operating improvement.

Current thesis in one line: CI Systems is currently supported by a strong defense engine and a successful first commercial step in microelectronics, but 2026 still has to prove that the new engine is repeatable and that more of the improvement survives in cash.

What really changed: The company is no longer only a niche supplier of defense test systems and sensors. It is now also selling a larger direct system to end customers in semiconductors. At the same time, the defense business became even more dominant in the revenue mix.

The strongest counter-thesis: One can argue that this caution goes too far, because the company is already showing record revenue, restored profitability, a comfortable cash position, zero bank debt and real WETALYZER progress, so a few more decent quarters may be enough for the market to recognize a new operating level.

What could change the market reading: Follow-on microelectronics orders, especially for WETALYZER, would be the sharpest catalyst. Better working-capital behavior would make that progress much more credible.

Why this matters: The real value in CI Systems will not come only from higher backlog or higher sales, but from the company's ability to turn the mix of defense demand and WETALYZER commercialization into a repeatable growth and profit model that still leaves cash after real uses.

Over the next 2 to 4 quarters the company has to show four things: that defense can keep growing without becoming even more concentrated, that microelectronics generates repeat orders rather than only first revenue, that the Taiwan and South Korea build-out improves commercialization faster than it raises cost, and that cash left after investment and lease obligations turns truly positive. What would weaken the thesis is the opposite: flat micro backlog, heavier working capital, or still greater dependence on one defense customer.